Ruxandra Teslo reports cases of people willing to fund and develop experimental treatments themselves being unable to get permissions, even with active cancers.
Around the same time, writer Jake Seliger faced a similar situation while battling advanced throat cancer. Like Sid Sijbrandij, he was willing to try anything that might help. The difference was that Seliger was not a billionaire. He could not hire a team to navigate the system on his behalf, and he struggled even to enroll in the clinical trials that might have offered him a chance.
A system originally conceived to safeguard patients has gradually produced a strange and troubling outcome: the mere chance of survival is effectively reserved for the very few who possess the means to assemble an army of experts capable of navigating its labyrinthine procedures.
One of these treatments was a personalised mRNA vaccine on a dog. Veterinary medicine has nearly as much bureaucracy as that for humans.
No comments:
Post a Comment